RSS

Analysis

Rapid growth from $1.64 billion in 2017 to $6.07 billion in 2024 is expected in the global orphan and rare dermatology premium products market, according to business intelligence provider, GBI Research. Read more

Analysis

After receiving approval for two HIV drugs, Delstrigo and Pifeltro, Merck should be expecting strong sales but probably unlikely to be at blockbuster levels, according to senior pharma analyst at GlobalData. Read more

Analysis

The recent approval of AstraZeneca/Merck’s Lynparza reflects the accelerating pace of Chinese drug approvals under the country’s new policy regime, according to data and analytics company, GlobalData. Read more

News

Transparency Market Research has predicted that the global pharmaceutical robots market is set to witness high adoption of regional expansion, new product development and merger & acquisition as key business strategies, bagging $250.46m by 2026 Read more

Analysis

Sanofi Genzyme — specialty care global business unit of French pharma company Sanofi — has launched its multiple sclerosis (MS) drug in India, however, according to GlobalData, it should be cautious of fierce generic competition… Read more

News

A stark warning that ‘innovation is being hindered by regulators’ has been given by the president of EPCOT International, Girish Malhotra, in the first part of CPhI Worldwide’s sixth annual report. Read more

Analysis

Amazon

Eric Broder Van Dyke / Shutterstock.com

According to data and analytics company, GlobalData, Amazon is poised to make huge strides within healthcare as its business model offers easier connectivity between providers and patients and it has a powerful online platform... Read more

News

According to poll results from Pew Research Center, the American public is accepting of gene editing in animals that could benefit human health, potentially removing a barrier to research, as noted by a pharma analyst at GlobalData. Read more

Opinion

In the latest annual snapshot of the manufacturing industry — published by the manufacturers’ organisation, EEF, and Santander — it has been shown that the sector contributes more than just the sum of its part. Read more

Analysis

The recent collaboration between Merck and InnoCore Pharmaceuticals for the development of a new drug delivery platform that will improve compliance could be a step forward in the delivery of biologics, according to GlobalData Read more

Opinion

Big data has the potential to provide scientists with important insights but there are still some barriers to its widespread use that need to be overcome. In this article, Paul Denny-Gouldson from IDBS tells us more… Read more

Opinion

A new report from Santander and the manufacturers’ organisation, EEF, has highlighted five key areas for growth in the UK’s pharmaceutical sector. Read more

Analysis

In order to reduce the high level of disabilities and stroke recurrence in cases of acute ischaemic stroke (AIS) it is vital that the diverse unmet needs are addressed, according to data and analytics company, GlobalData. Read more

Analysis

GlobalData has stated that according to its latest research immune-based gene therapy candidates should prevail in oncology, however, this novel approach is unchartered territory in oncology and will require new regulatory guidelines Read more

Analysis

From 20–22 June, the Shanghai New International Expo Center (SNIEC), Shanghai, China, will host the P-MEC China event, which is seen as an accurate gauge of industry growth potential and features a large exhibition and several in-depth conferences. Read more

Analysis

Here, Mark Tempest, VWV partner in the Insolvency and Restructuring and Pharmaceuticals and Life Sciences teams, looks at the construction giant’s case in more detail and what pharma and life sciences should consider in order to protect themselves. Read more

Opinion

As more pharma manufacturers outsource elements of their process, Steve Cottrell, president at Maetrics, looks at the importance of supply chain visibility and how companies can regain full control. Read more

Opinion

Biosimilar entry onto US market is slow despite implementation of the Biologics Price Competition and Innovation Act (BPCIA) by the Food and Drug Administration (FDA), according to data and analytics company, GlobalData. Read more

Analysis

Data and analytics company, GlobalData, has revealed that biosimilars to Humira will have significant uptake across Europe this year as a result of 10–20% lower prices compared with the originator brand. Read more

Analysis

New research from Oracle Health Services in partnership with Informa Engage/Pharma Intelligence has revealed that more than 60% of drug safety experts are planning to use artificial intelligence (AI) to improve the speed and security Read more

Analysis